Japan can­cels 140M dose or­der for No­vavax Covid vac­cine amid 'low­er than ex­pect­ed' de­mand

Japan has can­celed an or­der for more than 140 mil­lion dos­es of No­vavax’s Covid-19 vac­cine, Take­da re­vealed in an SEC fil­ing.

The coun­try ini­tial­ly agreed in 2021 to pur­chase 150 mil­lion dos­es of the vac­cine from Take­da, which has been pro­duc­ing No­vavax’s vac­cine at its Hikari-based fa­cil­i­ty. But af­ter on­ly pur­chas­ing 8.24 mil­lion dos­es, the Min­istry of Health, Labour and Wel­fare has can­celed the re­main­ing 141.76 mil­lion dos­es.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.